Shimatsu, [Ghrelin-related drugs: clinical perspectives], Nihon Rinsho Jpn
Purpose-built for physicians Semaglutide reduces CV events more than tirzepatide in real-world study Key takeaways: In a real-world cohort of patients with obesity and heart disease but not diabetes, semaglutide prevented more CV events than tirzepatide
The glucagon component increases energy expenditure and promotes fat oxidation, creating a synergistic effect that addresses multiple aspects of metabolic dysfunction simultaneously
(1) While this was an important evolutionary trait that kept early man alive, its more of an unsightly nuisance these days
The effects of cigarette smoking on serum oxidant status, and cholesterol, homocysteine, folic acid, copper, and zinc levels in university students